Author: Bill Snyder
Study explores treatment options for babies with cataracts
Jun. 26, 2019—Cataracts are uncommon in babies but when they occur the cloudy lenses must be removed without delay or blindness may result.
Awards honor profound impact of research staff
Jun. 20, 2019—Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 15th annual Research Staff Awards luncheon at the Kimpton Aertson Hotel in Nashville.
Patients of surgeons with higher reports of unprofessional behaviors are more likely to suffer complications
Jun. 19, 2019—Patients of surgeons with higher numbers of reports from co-workers about unprofessional behavior are significantly more likely to experience complications during or after their operations, researchers from Vanderbilt University Medical Center reported June 19.
New method tested to block chikungunya infection
Jun. 14, 2019—Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.
Steroid binding to metabolic enzyme
Jun. 12, 2019—Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer.
VUMC joins international effort to speed vaccine development
Jun. 6, 2019—VUMC has joined an international effort to streamline and accelerate development of vaccines and other treatments against a growing worldwide surge of deadly and debilitating viral infections.
Flu’s “hidden target” may lead to universal vaccine: study
May. 16, 2019—Researchers at Vanderbilt University Medical Center and the Scripps Research Institute have discovered a “hidden target” on the surface of the hypervariable influenza A virus that could lead to better ways to prevent and treat the flu.
Browser gives glimpse into rapidly growing “All of Us” databank
May. 9, 2019—The national “All of Us” Research Program, which aims to accelerate the prevention and treatment of illness by recruiting a million or more research participants, provided a glimpse this week into its rapidly growing databank with the beta launch of its publicly accessible Data Browser application.
New trans-institutional program to focus on genetic variations, disease
May. 9, 2019—A new program at Vanderbilt will help researchers determine more precisely how genetic variations contribute to disease and what potentially can be done to put them right.
Researchers putting the brakes on lethal childhood cancer
May. 3, 2019—Malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers. Although rare — about 20 to 25 new cases are diagnosed annually in the United States — there is no standard effective treatment for the disease, which is driven by loss of an anti-cancer protein called SNF5. The chances are very small that a child will survive a year after MRT diagnosis.
International Society of Nephrology honors Fogo
May. 2, 2019—Agnes Fogo, MD, an internationally known expert in kidney disease at Vanderbilt University Medical Center, has won the 2019 Roscoe Robinson Award from the International Society of Nephrology (ISN).
Immune ‘pruning’ in schizophrenia
Apr. 25, 2019—Ariel Deutch and colleagues have discovered that overactive brain immune cells during adolescence may contribute to schizophrenia.
